Universidad Peruana Cayetano Heredia
Clinical trials sponsored by Universidad Peruana Cayetano Heredia, explained in plain language.
-
Could a single dose beat brain worms? new trial aims to find out
Disease control Not yet recruitingThis study tests a drug called oxfendazole for people with mild brain cysticercosis (a parasitic infection causing one or two brain lesions). The goal is to see if one or a few doses can clear the parasites better than the current standard treatment. About 544 adults will take pa…
Phase: PHASE2, PHASE3 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated May 26, 2026 10:22 UTC
-
Could one dose beat two? new trial aims to simplify parasite treatment
Disease control Not yet recruitingThis study compares a new drug, oxfendazole, given as one or two doses, against the standard two-dose treatment with triclabendazole for chronic fascioliasis, a parasitic liver infection. About 336 adults in rural Peru will take part. The goal is to see if oxfendazole works just …
Phase: PHASE2 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated May 22, 2026 13:52 UTC